Updates in Chronic Spontaneous Urticaria From...

ADCs are moving from the metastatic setting into curative-intent neoadjuvant and adjuvant lines of treatment. Are you ready? Credit available for this activity expires: 10/5/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/antibody-drug-con ...  Show more

Do you know who to test, when to test, and which biomarker test to use? Credit available for this activity expires: 9/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/solving-alzheimers-disease-biomarker-puzzle-live-european-2026a1000y9g ...  Show more

Listen in as experts discuss the latest updates in AFib management. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/963752?src=mkm_podcast_addon_963752 

Join the experts for an in-depth discussion on the latest developments in targeted therapies for relapsed/refractory chronic lymphocytic leukemia (R/R CLL), and a look ahead to the upcoming EHA2024 conference. Credit available for this activity expires: 6/6/2025 Earn Credit / Lea ...  Show more

Join us for an insightful podcast exploring the latest milestones in the understanding and treatment of IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS). Discover how recent breakthroughs in our understanding of these conditions are advancing clinical research ...  Show more

Join us as we go through the JEADV Editor's Picks of November 2021: (1) Long-term safety data for a monoclonal antibody used in psoriasis (2) Preventing anaphylactoid symptoms following Covid-19 vaccination (3) Innovative surgery option for bromhidrosis (4) Surprising trends in s ...  Show more